Clinical Practice Guidelines
AAHKS has produced these guidelines specifically for hip and knee surgeons to use in their practices. Practice ResourcesCorticosteroids in Total Joint Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of primary TJA patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach to the use of corticosteroids following primary TJA. The guideline can also be found here.
Year released: 2022
Ketamine in Total Joint Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of primary TJA patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach to the use of ketamine in primary TJA. The guideline can also be found here.
Year released: 2022
Regional Nerve Blocks in Primary Total Knee Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of orthopedic surgical patients and reduce practice variationby promoting a multidisciplinary evidence-based approach to the use of regional nerve blocks following primary TKA. Click here to read more.
Year released: 2022
Regional Nerve Blocks in Primary Total Hip Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of orthopedic surgical patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach to the use of regional nerve blocks following primary THA. Click here.
Year released: 2020
Periarticular Injection in Total Joint Arthroplasty
Description: The purpose of these guidelines are to improve the treatment of primary TJA in patients and reduce practice variation by promoting a multidisciplinary, evidence-based approach for the use of periarticular injectionin primary TJA. Click here to read more.
Year released: 2022
Preventing Periprosthetic Joint Infection with Patients Undergoing Dental Procedures
Description: This guideline is based on a systematic review of published studies examining the influence of dental care and procedures on outcomes after total joint arthroplasty (TJA) as well as strategies to mitigate potential risks associated with dental care in patients with a TJA. The guideline can also be found here.
Year released: 2024
Regional Nerve Blocks in Primary Total Hip Arthroplasty
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of acetaminophen following primary TJA. Click here.
Year released: 2020
Acetaminophen in TJA
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of acetaminophen following primary TJA.
Year released: 2020
Optimal Timing of Total Hip and Knee Arthroplasty
Description: This guideline provides evidence-based consensus recommendations for the optimal timing of hip and knee arthroplasty on patient important outcomes from AAHKS and the American College of Rheumatology. The guideline can also be found here.
Year released: 2023
NSAIDs in TJA
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of NSAIDs following primary TJA.
Year released: 2020
Antirheumatic Drug Therapy
Description: Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty from AAHKS and the American College of Rheumatology.
Year released: 2017 – Updated 2022
Gabapentinoids in TJA
Description: The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of gabapentinoids following primary TJA.
Year released: 2020
Opioids in TJA
Description:The purpose of these guidelines is to improve the treatment of orthopaedic surgical patients and reduce practice variation by promoting a multidisciplinary evidenced-base approach on the use of opioids following primary TJA.
Year released: 2020
Tranexamic Acid in TJA
Description: The purpose of these guidelines is to improve the treatment of
orthopaedic surgical patients and reduce practice variation by promoting a
multidisciplinary evidence-based approach on the use of TXA.
Year released: 2018
